Skip to content
10-Q

Quarterly Report

Denali Therapeutics Inc. DNLI

0001714899-25-000193

← back to feed
Filed
Nov 6, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 146.66M sh
Shares Diluted Q3 2025 · Sep 30, 2025 172.42M sh
Shares Diluted Q3 2025 · Sep 30, 2025 171.7M sh
Shares Diluted Q3 2025 · Sep 30, 2024 169.46M sh
Shares Diluted Q3 2025 · Sep 30, 2024 162.59M sh
Capex Q3 2025 · Sep 30, 2025 $7.98M
Capex Q3 2025 · Sep 30, 2024 $10.82M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$314.06M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$263.98M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $90.96M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $174.96M
Stockholders Equity Q3 2025 · Sep 30, 2025 $926.2M
Stockholders Equity Q3 2025 · Jun 30, 2025 $1.03B
Stockholders Equity Q3 2025 · Dec 31, 2024 $1.23B
Stockholders Equity Q3 2025 · Sep 30, 2024 $1.32B
Stockholders Equity Q3 2025 · Jun 30, 2024 $1.39B
Stockholders Equity Q3 2025 · Dec 31, 2023 $1.03B
Current Liabilities Q3 2025 · Sep 30, 2025 $90.15M
Current Liabilities Q3 2025 · Dec 31, 2024 $102.21M
Total Liabilities Q3 2025 · Sep 30, 2025 $129.42M
Total Liabilities Q3 2025 · Dec 31, 2024 $144.5M
Current Assets Q3 2025 · Sep 30, 2025 $882.6M
Current Assets Q3 2025 · Dec 31, 2024 $864.44M
Total Assets Q3 2025 · Sep 30, 2025 $1.06B
Total Assets Q3 2025 · Dec 31, 2024 $1.37B
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.74
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.24
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.63
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.89
Eps Basic Q3 2025 · Sep 30, 2025 −$0.74
Eps Basic Q3 2025 · Sep 30, 2025 −$2.24
Eps Basic Q3 2025 · Sep 30, 2024 −$0.63
Eps Basic Q3 2025 · Sep 30, 2024 −$1.89
Sga Expense Q3 2025 · Sep 30, 2025 $35.48M
Sga Expense Q3 2025 · Sep 30, 2025 $97.1M
Sga Expense Q3 2025 · Sep 30, 2024 $24.95M
Sga Expense Q3 2025 · Sep 30, 2024 $75.38M
Rd Expense Q3 2025 · Sep 30, 2025 $101.95M
Rd Expense Q3 2025 · Sep 30, 2025 $320.87M
Rd Expense Q3 2025 · Sep 30, 2024 $98.24M
Rd Expense Q3 2025 · Sep 30, 2024 $296.65M
Net Income Q3 2025 · Sep 30, 2025 −$126.9M
Net Income Q3 2025 · Sep 30, 2025 −$383.99M
Net Income Q3 2025 · Sep 30, 2024 −$107.19M
Net Income Q3 2025 · Sep 30, 2024 −$308.02M
Operating Income Q3 2025 · Sep 30, 2025 −$137.43M
Operating Income Q3 2025 · Sep 30, 2025 −$417.98M
Operating Income Q3 2025 · Sep 30, 2024 −$123.19M
Operating Income Q3 2025 · Sep 30, 2024 −$357.5M